Out-of-Hospital Mortality Among Patients Receiving Methadone for Noncancer Pain
Authors:
Open Access
- 1 March 2015
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 175 (3) , 420-427
Abstract
Methadone hydrochloride, a μ-opioid agonist long used as evidence-based treatment for opioid dependence,1 has been increasingly prescribed for chronic pain. In 2009, 4.4 million methadone prescriptions in the United States were for treatment of pain, accounting for 9% of prescribed opioid analgesics on a dose-adjusted basis.1 Methadone's efficacy is comparable to that of other long-acting opioids2; however, its primary advantages as an analgesic are a long elimination half-life3 and low cost.1Keywords
This publication has 39 references indexed in Scilit:
- Trends in Reporting Methadone-associated Cardiac Arrhythmia, 1997–2011: An Analysis of Registry DataThe Journal of Emergency Medicine, 2013
- Validation of a computer case definition for sudden cardiac death in opioid usersBMC Research Notes, 2012
- Cause of Death Conundrum With Methadone UseAmerican Journal of Forensic Medicine & Pathology, 2011
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- A computer case definition for sudden cardiac deathPharmacoepidemiology and Drug Safety, 2009
- Use of disease risk scores in pharmacoepidemiologic studiesStatistical Methods in Medical Research, 2009
- Adjustment for Multiple Cardiovascular Risk Factors Using a Summary Risk ScoreEpidemiology, 2008
- A Community-Based Evaluation of Sudden Death Associated with Therapeutic Levels of MethadoneThe American Journal of Medicine, 2008
- Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarctionThe American Journal of Cardiology, 1988
- Clinical classification of cardiac deaths.Circulation, 1982